dc.contributor.author |
Chege, Boniface Mwangi |
|
dc.contributor.author |
Nyaga, Nelly Murugi |
|
dc.contributor.author |
Kaur, Prabjot Sehmi |
|
dc.contributor.author |
Misigo, Wycliffe Odhiambo |
|
dc.contributor.author |
Khan, Nelson |
|
dc.contributor.author |
Wanyonyi, Wycliffe Chisutia |
|
dc.date.accessioned |
2024-03-01T14:11:39Z |
|
dc.date.available |
2024-03-01T14:11:39Z |
|
dc.date.issued |
2023 |
|
dc.identifier.citation |
Chege, B. M., Nyaga, N. M., Kaur, P. S., Misigo, W. O., Khan, N., Wanyonyi, W. C., & Mwangi, P. W. (2023). The significant antidyslipidemic, hypoglycemic, antihyperglycemic, and antiobesity activities of the aqueous extracts of Agave Sisalana juice are partly mediated via modulation of calcium signaling pathways. Heliyon, 9(2). |
en_US |
dc.identifier.uri |
https://doi.org/10.1016/j.heliyon.2022.e12400 |
|
dc.identifier.uri |
http://ir-library.kabianga.ac.ke/handle/123456789/764 |
|
dc.description |
Article Journal on significant antidyslipidemic, hypoglycemic,
antihyperglycemic, and antiobesity activities of the aqueous
extracts of Agave Sisalana juice are partly mediated via
modulation of calcium signaling pathways |
en_US |
dc.description.abstract |
Plant species in the genus Agave, including Agave sisalana, have found extensive application in
African and Asian traditional medicine. Inspired by the use of the edible sweet sap known as
Aguamiel (obtained from specific mature agave species such as Agave salmiana) in Mexico by
diabetic patients to improve their diabetic condition, this study investigated the effects of Agave
sisalana extracts prepared by lyophilization, fermentation, and saponin extraction from sisal juice
in a rodent model of metabolic syndrome. The metabolic syndrome was induced by administering
a high fat and high fructose diet to freshly weaned Sprague-Dawley rats for eight weeks.
The A. sisalana extracts possessed significant hypoglycemic effects [3.883 ± 0.371 mmol/L
(normal group) vs. 8.183 ± 0.5845 mmol/L (negative control) vs. 3.767 ± 0.2716 mmol/L
(positive control) vs. 4.167 ± 0.4602 mmol/L (FSP) vs. 4.533 ± 0.3169 mmol/L (FerSP) vs. 3.5 ±
0.2309 mmol/L (FS LD) vs. 3.867 ± 0.3353 mmol/L (FS HD) vs. 4.617 ± 0.2725 mmol/L (FerS
LD) vs. 4.383 ± 0.3114 mmol/L (FerS HD): p < 0.0001]. The extracts also possessed significant
antihyperlipidemic effects with significant differences in total serum cholesterol between the
groups [1.398 ± 0.1232 mmol/L (normal group) vs. 4.225 ± 0.4135 mmol/L (negative control)
vs. 1.582 ± 0.154 mmol/L (positive control) vs. 1.245 ± 0.0911 mmol/L (FSP) vs. 1.393 ±
0.1423 mmol/L (FerSP) vs. 1.387 ± 0.0924 mmol/L (FS LD) vs. 1.761 ± 0.1495 mmol/L (FS HD)
vs. 1.698 ± 0.1294 mmol/L (FerS LD) vs. 1.6975 ± 0.0982 mmol/L (FerS HD): p < 0.0001].
Further, significant antiobesity effects of the A.sisalana extracts were observed with significant
differences in weight among the groups [196.3 ± 6.49 g (normal group) vs. 298.9 ± 6.67 g
(negative control) vs. 215.3 ± 6.06 g (positive control) vs. 195.4 ± 3.92 g (FSP) vs. 213.1 ± 5.21
g (FerSP) vs. 190.8 ± 6.49 g (FS LD) vs. 198.9 ± 4.31 g (FS HD) vs. 204.7 ± 4.78 g (FerS LD) vs.
208.7 ± 6.21 g (FerS HD): p < 0.0001]. Network pharmacology studies indicated that the chemical components found in sisal juice
primarily exert their effects by modulating the voltage-gated calcium channels CACNA1S, CACNA1D, and CACNA1C, in the beta cells of the islets of Langerhans. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Heliyon |
en_US |
dc.subject |
Antidyslipidemic |
en_US |
dc.subject |
Antihyperglycemic |
en_US |
dc.subject |
Antiobesity activities |
en_US |
dc.subject |
Aqueous extracts |
en_US |
dc.subject |
Agave Sisalana juice |
en_US |
dc.subject |
Calcium signaling pathway |
en_US |
dc.title |
The significant antidyslipidemic, hypoglycemic, antihyperglycemic, and antiobesity activities of the aqueous extracts of Agave Sisalana juice are partly mediated via modulation of calcium signaling pathways |
en_US |
dc.type |
Article |
en_US |